Metlife Inc (MET)
Financials · Life & Health Insurance · US stock · S&P 500 component
$103.57
▲ +1.39 (1.36%)
Fair valueFair
$111 +7.5% to fair value
$56fair band $95–$135$167
Day's range
$101.21 – $103.65
52-week range
$67.33 – $103.65
About Metlife Inc
MetLife is a major provider of life insurance, annuities, employee benefits and retirement products to individuals and institutions in the United States and abroad. Customers pay premiums and deposits, which the company invests in a large portfolio of bonds and other assets. It earns income from premiums, fees and investment returns, less the cost of paying benefits and claims, and interest rates and market conditions affect its results.
Over the last twelve months Metlife Inc reported revenue of $79.4 billion, which expanded at 3.9% a year across three years. Its operating margin is 8.3% and its return on invested capital is 845%. The company pays a dividend with a yield of 2.2%. The X-Ray Score is 56 out of 100, a summary of these measures.
Price chart
52-wk range $67.33 – $103.65Volume 3,505,871Daily, split-adjusted
Vitals
Market cap$67.0B
52-week range$67.33 – $103.65
Volume (last day)3,505,871
P/E (TTM)20.0
EBIT / EV yield16.2%
Free-cash-flow yield–
Dividend yield2.2%
Revenue (TTM)$79.4B
Net income (TTM)$3.4B
Operating margin8.3%
Return on capital844.7%
Debt incl. leases$460M
Cash & securities$27.3B
Debt = borrowings plus lease liabilities. Cash & securities = cash, equivalents and short-term marketable securities (long-term securities are not counted, so net cash can be understated for companies that hold large long-term investments). Net debt = debt minus cash & securities. Source: latest SEC 10-Q/10-K. EBIT / EV yield = operating profit divided by market cap plus net debt.
Fair value estimate
$111middle half of models $96 – $126
Fair
+7.5% to fair value
Average of the 4 valuation models that pass our checks: multiples, discounted cash flow, dividend discount and earnings power value. A model more than 100% above or 60% below the price is left out as unrealistic. Model uncertainty is Medium, based on how far apart the models are. Undervalued or Overvalued means the gap to fair value is more than 17.5%.
Price $104
Undervalued < $95Fair $95 – $135Overvalued > $135
P/E multiple
$99
P/B multiple
$89
P/S multiple
$124
Dividend discount, stable
$133
Dividend discount, multi-stage · not used
$279
A model estimate, not a price target or recommendation. Inputs: risk-free 5.13%, equity risk premium 4.30% (Damodaran). How it works.
What this means
Average business, fairly priced
The price sits inside our fair-value band. A high score does not guarantee a good outcome; it shifts the odds a little. Use the checklist as a prompt for your own research.
Before you invest · decision checklist
Ticked boxes are filled in from our data; the rest are yours to answer.
The five-lens scan
Every score explained in one sentence, ranked against Financials peers. Open a lens to see the numbers behind it.
Strong: 70 to 100Fair: 50 to 69Weak: under 50No score: not enough data
Valuation
Strong
72/100
Cheap against its sector on earnings and cash flow.
See the numbers →
EBIT / EV yield16.2%
Fair value vs price1.1×
Growth
Weak
29/100
Growing slower than most of its sector.
See the numbers →
Revenue growth (3y)3.9%
EPS growth (3y)-9.2%
Growth consistency70%
Profitability
Fair
66/100
Returns on capital are typical for its sector.
See the numbers →
Return on invested capital844.7%
Operating margin8.3%
Financial health
Fair
65/100
Balance sheet is in typical shape for its sector.
See the numbers →
Piotroski F-Score6 / 9
Net debt / EBITDA-4.1×
Interest coverNo interest cost
Dividends
Weak
29/100
Dividend is modest or less certain than peers.
See the numbers →
Dividend yield2.2%
Dividend growth-1.9%
Quarterly results: last 6 quarters
+15.6%
Mar '25
-2.7%
Jun '25
-5.9%
Sep '25
+27.6%
Dec '25
+2.7%
Mar '26
+10.5%
Jun '26
Revenue against the same quarter a year earlier. Latest quarter revenue $19.2B, diluted EPS $1.09.
Compare with peers
PFH Prudential Financial I...55 GL Globe Life Inc.49 PFG Principal Financial Gr...37 AFL Aflac Inc35Other Life & Health Insurance companies by X-Ray Score.
SWOT analysis: Metlife Inc
Strengthsinside the company
- Return on invested capital is 844.7%, against a median of 15.3% for industry peers.
- Cash exceeds debt (net debt is negative), which gives room to invest or ride out a downturn.
- Operating profit covers interest 50x, so debt costs are a small drag.
Weaknessesinside the company
- Operating margin of 8.3% is thin against 26.4% for industry peers.
- Earnings per share have declined 9.2% a year over three years.
Opportunitiesvaluation and setting
- Revenue growth picked up to 8.6% last year from 3.9% a year over three years.
- Our Market Compass rates the backdrop for Financials as favourable.
- Price momentum is strong on the weekly and monthly signals (trends can reverse).
Threatsvaluation and setting
- Trades at 19.6x earnings, 65% above the 11.9x median of industry peers, so the price already assumes better results.
Written by fixed rules from the figures on this page and the peer table below: filings, our fair value, the sector climate and the price trend. It summarises the data, it is not a forecast or advice.
Compare MET with peers and sector
Medians of 4 Life & Health Insurance peers and of 70 Financials stocks in our universe.
Largest peers (X-Ray Score): AFL 35, PFG 37, GL 49, PFH 55.
| Metric | MET | Peers | Sector |
|---|---|---|---|
| X-Ray Score (out of 100) | 56 | 43 | 50 |
| Valuation | 72 | 50 | 52 |
| Growth | 29 | 9 | 54 |
| Profitability | 66 | 47 | 48 |
| Financial health | 65 | 45 | 50 |
| Dividends | 29 | 49 | 54 |
Sector leaders: highest X-Ray Score in Financials
MET ranks #23 of 71 in Financials and #1 of 5 in Life & Health Insurance by X-Ray Score. A higher score is stronger on our five pillars; it is a ranking of facts, not a forecast.
Green means better than the peer median, red worse (only where a higher or lower figure is clearly better). A dash means too few companies report the figure. P/E, EV/EBITDA and price changes are not graded: a different level is not good or bad by itself.
Factor ratings for MET
Each factor is rated by where MET stands among the 71 Financials stocks in our universe.
Rating against the sector
Goodthe top third of these stocks
Averagethe middle third of these stocks
Badthe bottom third of these stocks
"Beats" is the share of those stocks it is ahead of.
Against its own history
The last columns set today's figure against the company's own median of its last five financial years:
▲ Betterbetter than its usual level
▼ Worseworse than its usual level
≈ In linewithin its usual range
For valuation factors Good means cheaper than most of the sector and Better means cheaper than usual for this company, which is not the same as a bargain.
In total: 1 Good · 4 Average · 3 Bad of 8
Growth: 0 · 1 · 2
Profitability: 0 · 1 · 1
Valuation: 1 · 2 · 0
| Factor | MET | Rating | Sector median | Own 5-year median | Against own history |
|---|---|---|---|---|---|
| Growth | |||||
| Revenue growth, 3 years a year | +3.9% | Bad beats 21% | +8.3% | – | – |
| Revenue growth, last year | +8.6% | Average beats 66% | +6.9% | +1.3% | ▲ Better |
| EPS growth, 3 years a year | −9.2% | Bad beats 9% | +12.7% | – | – |
| Profitability | |||||
| Net margin | 4.3% | Bad beats 7% | 21.8% | 4.1% | ≈ In line |
| Return on equity | 12.5% | Average beats 41% | 15.7% | 9.4% | ▲ Better |
| Valuation | |||||
| P/E ratio | 19.6x | Average beats 35% | 13.8x | 16.8x | ▼ Worse |
| Price / book | 2.4x | Average beats 42% | 2.2x | 1.9x | ▼ Worse |
| Price / sales | 0.8x | Good beats 98% | 3.1x | 0.8x | ≈ In line |
These ratings compare companies with each other and describe the past; they are not a forecast, a recommendation or part of the X-Ray Score. A factor is left out when its data is missing or meaningless (for example a P/E on negative earnings), and banks and insurers are rated only on the factors that apply to them. A dash in the history columns means fewer than three usable years.
Fundamentals checklist
● 4 Good · ● 3 Average · ● 4 BadCash quality
Earnings backed by cashAverage
Risk models
Piotroski F-ScoreAverage
Growth
EPS growth (3y)Bad
Revenue growth (3y)Bad
Growth consistencyBad
Balance sheet
Net debt / EBITDAGood
Interest coverGood
Valuation
Fair value vs priceAverage
EBIT / EV yieldGood
Profitability
Return on invested capitalGood
Operating marginBad
Each check is graded against the company's sector, not a fixed number. Checklist score 55/100.
Financials
| FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Revenue | $68.7B | $68.8B | $66.9B | $71.0B | $77.1B |
| Operating income | $9.2B | $6.0B | $5.7B | $6.0B | $6.1B |
| Net income | $6.4B | $2.4B | $1.4B | $4.2B | $3.2B |
| Operating cash flow | $12.3B | $13.0B | $13.7B | $14.6B | $17.1B |
| Operating margin | 13.3% | 8.7% | 8.6% | 8.4% | 8.0% |
| Free cash flow | – | – | – | – | – |
| Diluted EPS | $7.65 | $6.30 | $1.81 | $5.94 | $4.71 |
Fiscal years, from SEC filings.
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
| SMA 10 | 100.6 | Bullish |
| EMA 10 | 100.6 | Bullish |
| SMA 20 | 98.32 | Bullish |
| EMA 20 | 99.28 | Bullish |
| SMA 50 | 97.23 | Bullish |
| EMA 50 | 97.08 | Bullish |
| SMA 100 | 93.75 | Bullish |
| EMA 100 | 93.35 | Bullish |
| SMA 200 | 84.40 | Bullish |
| EMA 200 | 87.97 | Bullish |
Oscillators (daily)
| RSI (14) | 68.67 | Neutral |
| MACD (12, 26) | 1.53 | Bullish |
| Momentum (12) | 6.60 | Bullish |
| Stochastic %K (14) | 99.11 | Bearish |
| Williams %R (14) | -0.89 | Bearish |
| CCI (20) | 135.0 | Bearish |
Pivot points (classic, last session)
S3 99.53 | S2 100.4 | S1 102.0 | Pivot 102.8 | R1 104.4 | R2 105.3 | R3 106.9 |
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
2.32 USD
Yield on today's price
2.24%
Frequency
Quarterly
Next ex-dividend date
3 Nov 2026
| Ex-dividend date | Amount per share |
|---|---|
| (upcoming) | 0.5925 |
| 0.5930 | |
| 0.5930 | |
| 0.5680 | |
| 0.5680 | |
| 0.5680 | |
| 0.5680 | |
| 0.5450 | |
| 0.5450 | |
| 0.5450 | |
| 0.5450 | |
| 0.5200 |
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
ETFs that hold MET
| ETF | Share of the fund |
|---|---|
| KIE SPDR S&P Insurance | 1.76% |
| PWV Invesco Dynamic Large Cap Value | 1.52% |
| DVY iShares Select Dividend | 1.25% |
| RPV Invesco S&P 500 Pure Value | 0.92% |
| VOE Vanguard Mid-Cap Value | 0.80% |
| IYF iShares U.S. Financials | 0.79% |
| DFLV Dimensional US Large Cap Value | 0.63% |
| XLF Financial Select Sector SPDR | 0.60% |
The eight funds with the largest weight in MET among the ETFs we cover, from each fund's latest SEC Form N-PORT (quarter-end positions, so they can be months old). All ETFs.
MET SEC filings
8-KSEC EDGAR
Regulation FD disclosure
8-KSEC EDGAR
Other events
10-QSEC EDGAR
Quarterly report
8-KSEC EDGAR
Results of operations; Regulation FD disclosure
8-KSEC EDGAR
Regulation FD disclosure
8-KSEC EDGAR
Shareholder vote results
8-KSEC EDGAR
Other events
10-QSEC EDGAR
Quarterly report
Where the numbers come from
Statements SEC EDGAR filings (10-K, 10-Q), quarters derived from year-to-date figures.
Prices end-of-day closes, split-adjusted.
Industry inputs beta, multiples and equity risk premium from Damodaran Online (NYU Stern).
StocksXray is for education only and is not financial advice. Scores and fair values are model estimates from public filings and carry uncertainty.